Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.

Satlin MJ, Kubin CJ, Blumenthal JS, Cohen AB, Furuya EY, Wilson SJ, Jenkins SG, Calfee DP.

Antimicrob Agents Chemother. 2011 Dec;55(12):5893-9. doi: 10.1128/AAC.00387-11. Epub 2011 Oct 3.

2.

Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.

Dubrovskaya Y, Chen TY, Scipione MR, Esaian D, Phillips MS, Papadopoulos J, Mehta SA.

Antimicrob Agents Chemother. 2013 Nov;57(11):5394-7. doi: 10.1128/AAC.00510-13. Epub 2013 Aug 19.

3.

Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.

van Duin D, Cober ED, Richter SS, Perez F, Cline M, Kaye KS, Kalayjian RC, Salata RA, Evans SR, Fowler VG Jr, Bonomo RA.

Clin Microbiol Infect. 2014 Dec;20(12):O1117-20. doi: 10.1111/1469-0691.12714. Epub 2014 Dec 12.

4.

Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.

van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG Jr, Kaye KS, Bonomo RA.

J Antimicrob Chemother. 2015 Apr;70(4):1203-11. doi: 10.1093/jac/dku495. Epub 2014 Dec 9.

5.

Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.

Lee GC, Burgess DS.

Ann Clin Microbiol Antimicrob. 2012 Dec 13;11:32. doi: 10.1186/1476-0711-11-32. Review.

6.

Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.

Mouloudi E, Massa E, Piperidou M, Papadopoulos S, Iosifidis E, Roilides I, Theodoridou T, Kydona C, Fouzas I, Imvrios G, Papanikolaou V, Gritsi-Gerogianni N.

Transplant Proc. 2014 Nov;46(9):3219-21. doi: 10.1016/j.transproceed.2014.09.160.

PMID:
25420864
7.

[Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].

Huan J.

Zhonghua Shao Shang Za Zhi. 2015 Feb;31(1):5-8. Chinese.

PMID:
25876631
8.

Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.

Zhang R, Cai JC, Zhou HW, Nasu M, Chen GX.

J Med Microbiol. 2011 Dec;60(Pt 12):1813-9. doi: 10.1099/jmm.0.025668-0. Epub 2011 Aug 11.

PMID:
21835972
9.

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.

Rodríguez-Avial C, Rodríguez-Avial I, Merino P, Picazo JJ.

Clin Microbiol Infect. 2012 Jan;18(1):61-6. doi: 10.1111/j.1469-0691.2011.03482.x. Epub 2011 Jul 1.

10.

Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.

van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA, Kaye KS.

Infect Control Hosp Epidemiol. 2015 Aug;36(8):942-8. doi: 10.1017/ice.2015.118. Epub 2015 May 20.

11.

Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.

Nguyen M, Eschenauer GA, Bryan M, O'Neil K, Furuya EY, Della-Latta P, Kubin CJ.

Diagn Microbiol Infect Dis. 2010 Jun;67(2):180-4. doi: 10.1016/j.diagmicrobio.2010.02.001. Epub 2010 Mar 31.

PMID:
20356699
12.

Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.

Ny P, Nieberg P, Wong-Beringer A.

Am J Infect Control. 2015 Oct 1;43(10):1076-80. doi: 10.1016/j.ajic.2015.06.008. Epub 2015 Jul 17.

PMID:
26190386
13.

Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.

Brizendine KD, Richter SS, Cober ED, van Duin D.

Antimicrob Agents Chemother. 2015 Jan;59(1):553-7. doi: 10.1128/AAC.04284-14. Epub 2014 Nov 10.

14.

Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection.

Lee J, Patel G, Huprikar S, Calfee DP, Jenkins SG.

J Clin Microbiol. 2009 May;47(5):1611-2. doi: 10.1128/JCM.02466-08. Epub 2009 Mar 4. No abstract available.

15.
16.

Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.

Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, Bonomo RA, Shrestha NK, Fraser TG, van Duin D.

Diagn Microbiol Infect Dis. 2011 Apr;69(4):357-62. doi: 10.1016/j.diagmicrobio.2010.10.013.

17.

Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options.

Kontopidou F, Giamarellou H, Katerelos P, Maragos A, Kioumis I, Trikka-Graphakos E, Valakis C, Maltezou HC; Group for the Study of KPC-producing Klebsiella pneumoniae infections in intensive care units.

Clin Microbiol Infect. 2014 Feb;20(2):O117-23. doi: 10.1111/1469-0691.12341. Epub 2013 Aug 30.

18.

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.

Vasilev K, Reshedko G, Orasan R, Sanchez M, Teras J, Babinchak T, Dukart G, Cooper A, Dartois N, Gandjini H, Orrico R, Ellis-Grosse E; 309 Study Group.

J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i29-40. doi: 10.1093/jac/dkn249.

19.

Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.

Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, Kassis I.

J Hosp Infect. 2013 Apr;83(4):307-13. doi: 10.1016/j.jhin.2012.10.012. Epub 2013 Jan 10.

PMID:
23313086
20.

Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.

Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R.

Infect Control Hosp Epidemiol. 2009 Jul;30(7):666-71. doi: 10.1086/598244.

PMID:
19496647
Items per page

Supplemental Content

Write to the Help Desk